Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Biotech Valuation -- Ignore unavailable to you. Want to Upgrade?

To: Doc Bones who wrote (2821)	2/5/2001 7:27:55 PM
From: Biomaven	Respond to of 52153

Very nice results, Doc. Reminds me of DAK's old "Blind Squirrel" portfolio. Clearly this is where I should have had my money rather than the dogs like SEPR this year. <g> Peter

To: Doc Bones who wrote (2821)	2/5/2001 8:50:11 PM
From: scaram(o)uche	Read Replies (1) \| Respond to of 52153

You know who you are, TIA. <g> As Mike would say..... heh, heh, heh. I said it in a post a few days ago....... real-world, the sins of November and December are gone. Easy pickings. Some years we get predominately deferral of profits to January. Off years we get predominately tax-related selling. I had a beer with a SI biofreak last week, after we had hit a seminar at U.C. Berkeley by Harvey Lodish. He plays his tricks almost exclusively in December and January. The average investor knows that a January effect is coming. We know which stocks are backed by good science and are therefore unlikely to implode. While the rest of the world is getting ready to ride bonds, we can retain our large appetites. Doc......... send your [sensational!] results to biotech antagonist James Cramer. Give him four or five years to match the yields.